drugset / Trial / NCT07414316
A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Phase 0
Recruiting
10 enrolled
Beijing Geekgene Technology Co., LTD
The First Affiliated Hospital of Nanchang University · collab
NaSingle-groupOpen-labelTreatment
Summary
A Single-Center, Open-Label Clinical Study to Evaluate the Safety, Preliminary Efficacy of GK01 Cell Injection in Subjects with Advanced Solid Tumors Refractory or Intolerant to Standard Therapy
Timeline
- Start
- 2026-02-13
- Primary completion
- 2027-02-12
- Completion
- 2028-02-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GK01 | Cell therapy | — | — |